To further understand the molecular mechanisms of TMEM119 in progression of ovarian cancer, we conducted GSEA analyses in the transcriptomic data of OV patients from the TCGA database (Fig. 4a) and in the transcriptomic data of 44 ovarian cancer cell lines from the CCLE project (Fig. 4b), respectively. Here, TMEM119 is linked to ovarian carcinoma.